HPV Vaccine – AVOID !

china-hpv
China’s drug regulator is refusing to release the safety reports on the Cervarix HPV vaccine ahead of the drug’s national launch next year. The vaccine manufactured by GlaxoSmithKline (GSK), and supposedly designed to prevent cervical cancer, is to be made available to all girls in China aged from nine years in 2017.

Ahead of the launch (September 2016), it is reported to have been tested on 6,000 Chinese girls, but authorities are refusing to release the toxicology reports and clinical trial data that would reveal any side effects and adverse reactions suffered by the girls.

This is at the very least suspect. One reason for the secrecy could be because the results of the trial pointed to a serious issues which GSK may not want to disclose. At the very minimum, it could be because the trial was not properly constructed, and the vaccine was never tested against an inert placebo. As a result, adverse reactions could be experienced by those given the vaccine or the placebo, so reducing the risk profile of the vaccine itself.

Dr Sin Hang Lee, who studied in China but now lives in the US, says HPV vaccines have not prevented a single case of cervical cancer, and yet have been associated with tens of thousands of reports of adverse reactions in young girls, ranging from nervous disorders, chronic disabilities and even death.

Elsewhere in the world, the Japanese government withdrew its recommendation for the HPV vaccine in 2013, after highly publicized cases of alleged adverse events in girls who had been vaccinated and several cases of parents suing the government and the vaccine makers for damages due to HPV vaccination. So currently the vaccine cannot be actively promoted, though parents can choose to vaccinate, if they understand the risks. Moreover, Japan has put in place a scheme to deal with chronic symptoms after HPV vaccination

April 2017 Update: the US agency CDC updates the “immunization” schedule and adds new HPV vaccine with double the aluminium (a well-known neurotoxic). New recommendations say the vaccine can be administered as young as 9 years old but with an average of 11 or 12 for the first dose.

However, the American College of Pediatricians (ACP) expressed serious concerns about Gardasil in January of 2016. The HPV vaccine has been linked with POF (premature ovarian failure, or “premature menopause”), as well as amenorrhea (absence of menstruation).

Gardasil also contains polysorbate 80, a compound linked with ovarian toxicity in experiments done with rats. Polysorbate 80 has also been connected with severe anaphylactic reactions, encephalitis and multiple sclerosis.

Other disturbing effects of the HPV vaccine are autoimmune conditions, permanent disability and early death in young women. For instance: http://www.ageofautism.com/2011/09/michele-bachman-meet-dr-diane-harper-lead-researcher-for-gardasil-vaccine.html

Despite these HPV vaccine side effects, a new “super” version of the HPV vaccine called 9vHPV vaccine is now being pushed. The vaccine makers claim the new version targets nine strains of HPV and 80 percent of vulvar, cervical and anal cancers, up from 65 percent by the previous version. It’s being sold under the name Gardasil 9 and is being marketed as an “improvement” over the previous version.

Isn’t this good news? Don’t we need protection against the HPV virus?

Despite these claims made for it, Gardasil 9 has double the toxic aluminum of the previous one. How the potential risks of aluminum exposure are worth any supposed benefits is hard to believe by any reasonable (thinking) person.

The World Health Organization (WHO) has found that the death rate from cervical cancer is actually 2.5 times LOWER than the very serious complications and side effects documented from the HPV vaccine. In some parts of the world, HPV vaccine risks are as much as FOUR TIMES higher than the cervical cancer death rate.

Find out the truth about vaccines here:
http://pilatesfitness.co.uk/blog/?p=677

REFERENCES

https://wddty.com/news/2016/09/china-refuses-to-release-safety-record-of-hpv-vaccine-ahead-of-national-launch.html

HPV Vaccination Controversy in Japan, Rates Plummet to 1% – http://www.medscape.com/viewarticle/866405

Victims in Japan Sue for Damages Due to Gardasil and Cervarix HPV Vaccines

http://www.naturalhealth365.com/immunization-schedule-2217.html

http://www.ageofautism.com/2011/09/michele-bachman-meet-dr-diane-harper-lead-researcher-for-gardasil-vaccine.html

 

 

 

This entry was posted in HPV and tagged , , . Bookmark the permalink.

Leave a Reply